Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4+CD25+ Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor

Overview of attention for article published in Frontiers in immunology, November 2021

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 33,039 followers.

RT @FrontImmunol: New Research: Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4+CD25+ Ts2 Regulatory Cells That…

30 Nov 2021

Reply Repost Favourite

New Research: Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4+CD25+ Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor: CD4+CD25+Foxp3+T cell population is heterogenous and contains three major… https://t.co

29 Nov 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.